Dr. FERHAT DEMIR

• 2018Karadeniz Technical University Faculty of Medicine Pediatric Rheumatology
• 2016Pediatric Rheumatology International Trial Organisation (PRINTO),Pediatric Rheumatology, Pediatria II, Pediatria Rheumatologia, Malattie Rare, Gaslini, Genova, Italy / Fellowsip
• 2014Kanuni Sultan Süleyman Training and Research Hospital Child Health and Diseases
• 2009Istanbul University Cerrahpasa Medical Faculty

Experience

• 2021Acıbadem Health Group
• 2018 – 2021Ümraniye Training and Research Hospital / Pediatric Rheumatology Specialist Doctor
• 2015 – 2018Karadeniz Technical University / Department of Pediatric Rheumatology / Pediatric Rheumatology Sub-branch Assistant
• 2014 – 2015Şanlıurfa Child Health and Diseases Hospital, Şanlıurfa / Child Health and Diseases Specialist
• 2011 – 2014Kanuni Sultan Suleyman Training and Research Hospital, Istanbul
• 2009 – 2014Child Health and Diseases Assistant
• 2009 – 2011Bakirkoy Yenimahalle Maternity and Child Health and Diseases Hospital

• Turkish Pediatric Rheumatology Association
• European Association of Paediatric Rheumatology

• Drug survival of the infliximab biosimilar (CT- P13) in paediatric patients with non-infectious uveitis.Clin Exp Rheumatol. 2021 Feb 9. Sözeri B, Kardeş E, Salı E, Çakır D, Demir F.
• Clinical course of COVID-19 in children with rheumatic disease under biologic therapyClin Exp Rheumatol. 2021 Jan-Feb;39 Demir F, Ulu K, Çağlayan Ş, Coşkuner T, Sözeri B.
• Hepatitis B vaccination response of treatment-naive patients with juvenile idiopathic arthritis.Rheumatol Int. 2021 Mar 18. doi: 10.1007/s00296-021-04833-3. Cakmak F, Cakan M, Demir F, Sönmez HE, Cakmak S, Demîrkan FG, Karadağ ŞG, Ayaz NA, Sözeri B.
• Comparison of the clinical diagnostic criteria and the results of the next-generation sequence gene panel in patients with monogenic systemic autoinflammatory diseasesClin Rheumatol. 2021 Jun;40(6):2327-2337. doi: 10.1007/Sİ0067-020-05492-8. Sözeri B, Demir F, Sönmez HE, Karadağ ŞG, Demirkol YK, Doğan ÖA, Doğanay HL, Ayaz NA.
• Adherence to best practice consensus guidelines for familial Mediterranean fever: a modified Delphi study among paediatric rheumatologists in TurkeyEker Omeroglu R, Aktay Ayaz N; PeRA-Research Group. Rheumatol Int. 2021 Jan 16:1-8. doi: 10.1007/s00296-020-04776-l. Kavrul Kayaalp G, Sözeri B, Sönmez HE, Demir F, Cakan M, Oztürk K, Karadağ SG, Otar Yener G, Ozdel S, Bağlan E, Celikel E, Şahin N, Gezgin Yildirim D,
• Hematological involvement in pediatric systemic lupus erythematosus: A multi-center studyLupus. 2021 May 6:9612033211014271. doi: 10.1177/09612033211014271. K Akça Ü, Batu ED, Kısaarslan AP, Poyrazoğlu H, Ayaz NA, Sözeri B, Sağ E, Atalay E, Demir S, Karadağ ŞG, Demir F, Bilginer Y, Gümrük F, Özen S.
• Time to collaborate: Objectives, design, and methodology of PeRA-Research Group.North Clin Istanb. 2021 Feb 25;8(2):200-202. doi: 10.14744/nci.2020.25826. Sözeri B, Emine Sönmez H, Demir F, Cakan M, Ozturk K, Ozdel S, Otar Yener G, Gul Karadağ S, Aktay Ayaz N.
• Neuroimaging of Children With Takayasu Arteritis.J Child Neurol. 2021 Feb 16:883073821991287. doi: 10.1177/0883073821991287. Sönmez HE, Demir F, Özdel S, Karadağ ŞG, Bağlan E, Bülbül M, Çakan M, Ayaz NA, Sözeri B.
• Plasma microRNA levels in childhood IgA vasculitisCLINICAL RHEUMATOLOGY, Doi: 10.1007/sl0067-020- 05441-5 (2020) ÇEBI ALPER HAN, DEMİR FERHAT, İkbal Mevlit, KALYONCU MUKADES
• A striking treatment option for recalcitrant calcinosis in juvenile dermatomyosistis: tofatinibe citrate.RHEUMATOLOGY, Doi:l 0.1093/rheumatolog y/keaa360 (2020) Sözeri Betül, Demir Ferhat